Aclaris Therapeutics Soars After Promising Study Against Rheumatoid Arthritis
January 20, 2021 at 07:45 AM EST
During the trading day yesterday, Aclaris Therapeutics’ stock shot upwards with a rise of more than 200%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|